A venture builder and fund is looking to invest in US-based neurotechnology device companies advancing transformative diagnostics and therapies. The firm offers 3 different opportunities to support companies: (1) grants to academic researchers whose research aligns with the firm’s interests, (2) venture creation where the firm helps founders create, augment, and support companies, and (3) traditional equity investing. The firm engages in Pre-Seed to Series A rounds with typical check sizes ranging from $250k-2M USD.
The firm primarily invests in medical devices that address stress and anxiety, sleep, and pain. The firm is open to working with companies from in-development stages. The firm is also open to take a leap on long-shot technologies that have potential to make significant changes in the neurotechnology space.
The firm does not have specific management team requirements and typically does not lead.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment